title: Magnetic resonance imaging follow-up in patients with acute leukemia during induction chemotherapy.
authors.affiliation: Dept. Internal Medicine, University of Münster, FRG.
authors.forename: C
authors.initials: C
authors.lastname: Kusnierz-Glaz
authors.forename: M
authors.initials: M
authors.lastname: Reiser
authors.forename: B
authors.initials: B
authors.lastname: Hagemeister
authors.forename: T
authors.initials: T
authors.lastname: Büchner
authors.forename: W
authors.initials: W
authors.lastname: Hiddemann
authors.forename: J
authors.initials: J
authors.lastname: van de Loo
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001853:Bone Marrow / Q000473:pathology; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D006801:Humans; D007938:Leukemia / Q000188:drug therapy / Q000473:pathology*; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D008942:Mitoxantrone / Q000008:administration & dosage; D012074:Remission Induction; D013866:Thioguanine / Q000008:administration & dosage
chemical_list: D003561:Cytarabine; D008942:Mitoxantrone; D013866:Thioguanine; D003630:Daunorubicin